The effect of TG2-inhibitory monoclonal antibody zampilimab on tissue fibrosis in human in vitro and primate in vivo models of chronic kidney disease

Huang, L., Bon, H., Maamra, M. et al. (11 more authors) (2024) The effect of TG2-inhibitory monoclonal antibody zampilimab on tissue fibrosis in human in vitro and primate in vivo models of chronic kidney disease. PLOS ONE, 19 (5). e0298864. ISSN 1932-6203

Abstract

Metadata

Item Type: Article
Authors/Creators:
Editors:
  • Bader, M.
Copyright, Publisher and Additional Information:

© 2024 Huang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Keywords: Animals; Humans; Fibrosis; Rabbits; Macaca fascicularis; Renal Insufficiency, Chronic; Protein Glutamine gamma Glutamyltransferase 2; Disease Models, Animal; Transglutaminases; GTP-Binding Proteins; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Male; Kidney
Dates:
  • Published: 16 May 2024
  • Published (online): 16 May 2024
  • Accepted: 1 February 2024
  • Submitted: 28 July 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine and Population Health
Depositing User: Symplectic Sheffield
Date Deposited: 21 May 2024 07:34
Last Modified: 21 May 2024 07:34
Status: Published
Publisher: Public Library of Science (PLoS)
Refereed: Yes
Identification Number: 10.1371/journal.pone.0298864
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics